Genetic Test Evaluation

understanding how genetic tests impact patient management

FoundationOneHeme (Foundation Medicine Inc.)

January 18, 2018

Molecular diagnostic testing for hematologic malignancies and sarcomas currently involves the use of multiple assays, each designed to detect a specific type of genomic alteration. The detection of these alterations may help with determining prognosis or driving treatment. It has been suggested that a comprehensive test that simultaneously assesses for these different types of genomic alterations may enhance diagnostic capabilities and offer increased opportunities for targeted therapy. This report reviews 1 such test, the FoundationOneHeme test.